Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study

被引：0
作者：
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] EBMT Study Off, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] European Inst Oncol, Milan, Italy
[5] Ctr Leon Berard, F-69373 Lyon, France
[6] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[7] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[8] Erciyes Univ, Kayseri, Turkey
[9] Portuguese Inst Oncol, Oporto, Portugal
[10] Univ Milan, Milan, Italy
[11] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Pavia, Italy
[12] Ist Ospitalieri Cremona, Cremona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15536
引用
收藏
页数：1
相关论文
共 50 条
[41]   Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT) [J].
De Giorgi, U. ;
Richard, S. ;
Badoglio, M. ;
Kanfer, E. ;
Bourrhis, J. H. ;
Nicolas-Virelizier, E. ;
Vettenranta, K. ;
Lioure, B. ;
Martin, S. ;
Dreger, P. ;
Schuler, M. K. ;
Thomson, K. ;
Scarpi, E. ;
Rosti, G. ;
Selle, F. ;
Mangili, G. ;
Lanza, F. ;
Bregni, M. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1910-1916
[42]   Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience [J].
De Giorgi, U ;
Demirer, T ;
Wandt, H ;
Taverna, C ;
Siegert, W ;
Bornhauser, M ;
Kozak, T ;
Papiani, G ;
Ballardini, M ;
Rosti, G .
ANNALS OF ONCOLOGY, 2005, 16 (01) :146-151
[43]   Superior survival after sequential high-dose chemotherapy (HDCT) as compared to single HDCT in patients with relapsed or refractory germ cell tumors (GCT): Six-year long-term follow-up of a prospective, randomized phase II trial. [J].
Lorch, A. ;
Kleinhans, A. ;
Kramar, A. ;
Hartmann, J. T. ;
Bokemeyer, C. ;
Rick, O. ;
Beyer, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[44]   Phase 2 trial of bevacizumab (BEV)/high-dose chemotherapy (HDC) with autologous stem-cell transplant (ASCT) for refractory germ-cell tumors (GCT). [J].
Nieto, Yago ;
Tu, Shi-Ming ;
Jones, Roy B. ;
Tannir, Nizar M. ;
Bassett, Roland L. ;
Margolin, Kim Allyson ;
Holmberg, Leona ;
Champlin, Richard E. ;
Pagliaro, Lance C. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[45]   High-dose chemotherapy (HDCT) and peripheral-blood stem cell transplant (PBSCT) in patients age 40 or older with relapsed metastatic germ-cell tumors (mGCT). [J].
Agrawal, Vaibhav ;
Althouse, Sandra K. ;
Abonour, Rafat ;
Abu Zaid, Mohammad Issam ;
Sullivan, Cheryl K. ;
Hanna, Nasser H. ;
Einhorn, Lawrence H. ;
Adra, Nabil .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[46]   Can patients (pts.) with refractory germ cell tumors (GCT) be cured after progression following high dose chemotherapy (HDCT) with tandem transplant? Results with paclitaxel plus gemcitabine. [J].
Lewis, D. A. ;
Brames, M. J. ;
Einhorn, L. H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :238S-238S
[47]   Second-line high-dose chemotherapy in patients with extragonadial nonseminomatous germ cell tumors: the experience of the European Group for Blood and Marrow Transplantation (EBMT) [J].
De Giorgi, Ugo ;
Demirer, Taner ;
Wandt, Hannes ;
Taverna, Christian ;
Siegert, Wolfgang ;
Borhauser, Martin ;
Kozak, Tomas ;
Papiani, Giorgio ;
Ballardini, Michela ;
Rosti, Glovanni .
ANNALS OF ONCOLOGY, 2004, 15 :121-121
[48]   Standard-dose salvage chemotherapy in patients with refractory metastatic germ-cell tumors (mGCT) progressing after high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT). [J].
Agrawal, Vaibhav ;
Althouse, Sandra K. ;
Hanna, Nasser H. ;
Einhorn, Lawrence H. ;
Adra, Nabil .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[49]   Prognostic value of FDG-PET before high-dose (HD) chemotherapy (CTX) in metastatic germ-cell tumors (GCT): Correlation with CT and MRI [J].
Pfannenberg, AC ;
Dohmen, BM ;
Bokemeyer, C .
RADIOLOGY, 1998, 209P :169-169
[50]   Efficacy of epirubicin-paclitaxel (EPI-TAX) prior to high-dose chemotherapy (HDCT) in germ cell tumors (GCTs): A 17-year experience. [J].
Lotz, Jean-Pierre ;
Soares, Daniele Grazziotin ;
Culine, Stephane ;
Laverdant, Benjamin ;
Kieffer, Anne ;
Dabi, Yohann ;
Gligorov, Joseph ;
Selle, Frederic .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345